Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE): A Phase 3 Randomized Clinical Trial.
Louie AV, Granton PV, Fairchild A, Bezjak A, Gopaul D, Mulroy L, Brade A, Warner A, Debenham B, Bowes D, Kuk J, Sun A, Hoover D, Rodrigues GB, Palma DA. Louie AV, et al. Among authors: kuk j. JAMA Oncol. 2022 Apr 1;8(4):1-7. doi: 10.1001/jamaoncol.2021.7664. JAMA Oncol. 2022. PMID: 35201290 Free PMC article. Clinical Trial.
Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
Chow E, Meyer RM, Ding K, Nabid A, Chabot P, Wong P, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, Brundage M, DeAngelis C, Wong RKS. Chow E, et al. Among authors: kuk j. Lancet Oncol. 2015 Nov;16(15):1463-1472. doi: 10.1016/S1470-2045(15)00199-0. Epub 2015 Oct 18. Lancet Oncol. 2015. PMID: 26489389 Clinical Trial.
Prophylactic dexamethasone for radiation-induced bone-pain flare - Authors' reply.
Chow E, Meyer RM, Ding K, Nabid A, Chabot P, Wong P, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, Brundage M, DeAngelis C, Wong RKS. Chow E, et al. Among authors: kuk j. Lancet Oncol. 2016 Feb;17(2):e40-e41. doi: 10.1016/S1470-2045(16)00029-2. Lancet Oncol. 2016. PMID: 26868346 No abstract available.
Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Brundage M. Raman S, et al. Among authors: kuk j. Qual Life Res. 2016 Oct;25(10):2535-2541. doi: 10.1007/s11136-016-1308-4. Epub 2016 May 2. Qual Life Res. 2016. PMID: 27138964 Clinical Trial.
A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M. Raman S, et al. Among authors: kuk j. Radiother Oncol. 2016 May;119(2):208-12. doi: 10.1016/j.radonc.2016.04.035. Epub 2016 May 3. Radiother Oncol. 2016. PMID: 27157890 Clinical Trial.
Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
McDonald R, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar R, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M. McDonald R, et al. Among authors: kuk j. Support Care Cancer. 2016 Dec;24(12):4871-4878. doi: 10.1007/s00520-016-3341-9. Epub 2016 Jul 27. Support Care Cancer. 2016. PMID: 27465049
Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
McDonald R, Ding K, Brundage M, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Chan S, Chow E. McDonald R, et al. Among authors: kuk j. JAMA Oncol. 2017 Jul 1;3(7):953-959. doi: 10.1001/jamaoncol.2016.6770. JAMA Oncol. 2017. PMID: 28196208 Free PMC article.
Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
Chow S, Ding K, Wan BA, Brundage M, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Chow E. Chow S, et al. Among authors: kuk j. Am J Hosp Palliat Care. 2018 Apr;35(4):718-723. doi: 10.1177/1049909117733435. Epub 2017 Sep 26. Am J Hosp Palliat Care. 2018. PMID: 28950727
Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial.
Chow S, Ding K, Wan BA, Brundage M, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Chow E. Chow S, et al. Among authors: kuk j. Ann Palliat Med. 2017 Dec;6(Suppl 2):S185-S194. doi: 10.21037/apm.2017.08.12. Epub 2017 Aug 29. Ann Palliat Med. 2017. PMID: 29156903 Free article. Clinical Trial.
Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial.
Ashram S, Bahig H, Barry A, Blanchette D, Celinksi A, Chung P, Darko J, Donath D, Doucet R, Erickson A, Giuliani M, Gopaul D, Hipwell S, Javor J, Kuk J, Lindsay P, Millman B, Oliver M, Pearce A, Russell C, Senthi S, Vu T, Warner A, Gaede S, Palma DA. Ashram S, et al. Among authors: kuk j. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):1011-1015. doi: 10.1016/j.ijrobp.2022.05.035. Epub 2022 Jun 3. Int J Radiat Oncol Biol Phys. 2022. PMID: 35667527 Clinical Trial. No abstract available.
211 results